SCRC CORE SHAREHOLDERS : > POWERFULL REVENUE NEWS OUT THIS

New Post Public Reply Private Reply Replies (0) Message Board
tryz
SCRC CORE SHAREHOLDERS : > POWERFULL REVENUE NEWS OUT THIS MORNING!!!.....OUR JOURNEY BEGINS: > ....May 21, 2014 - 8:00 AM EDT

ScripsAmerica Reports 126% Quarterly Revenue Growth YoY During Q1 2014
Company Records Over $5 Million in Revenue During Q1 2014 and CEO Comments on Revenue Recognition
TYSONS CORNER, VA--(Marketwired - May 21, 2014) - ScripsAmerica Inc. (OTCBB: SCRC) today announced the filing of its 10Q for the quarter that ended March 31, 2014.

The Company reported $5,097,000 in revenue during Q1 2014 compared to $2,256,000 in Q1 2013, marking a 126% increase in quarterly revenue year over year. ScripsAmerica's 2014 first quarter revenue from operations as reported in the 'Statement of Operations' in the Company's latest 10Q filing was $823,859, marking an increase of 187% over the same period in 2013 when it was reported at $287,374.

Gross profit during Q1 2014 was $598,000 compared to a loss of $11,000 for Q1 2013. The Company generated $3,687,222 in revenue from its joint government contract during the first quarter of 2014 compared to $1,955,345 during Q1 2013. This increase of $1,731,877 in quarterly revenue equals an 88% YoY growth rate for this contract.

This revenue is reported on page 30 of ScripsAmerica's 10Q in the 'Products Sold' column in the 'Revenue Net' section in addition to $793,000 in Q1 revenue from its pharmaceutical partner. Due to financial reporting requirements, ScripsAmerica can report only the net profits from its joint government contract and pharmaceutical partner, Wholesale Rx and not its top line revenue.

Commenting on ScripsAmerica's first quarter results, CEO Bob Schneiderman stated, "ScripsAmerica is pleased to report very positive financial results during the first quarter of 2014, marking the strong start we expected for what we believe will be a breakout year for the Company and its shareholders.

"It is also very important to remind the investment community that the Company's necessary accounting method has a significant impact on the reportable revenues from our government joint venture and Wholesale Rx investment, both of which will continue to generate revenue and profits for ScripsAmerica.

"The Company experienced tremendous growth across the business from our pharmaceutical equity venture with WRx to receiving an initial order for RapiMed in Asia as well as taking on the management of a specialty pharmacy that generated revenues of $494,643 in March before nearly doubling to $958,234 in April.

"We expect to see continued revenue growth in the upcoming quarters from our managed specialty pharmacy, equity ventures with WRx and PIMD International and our joint government contract which should lead to a sizeable increase in shareholder value."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.




ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 120

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 79

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 111

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 73

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 94

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
Mimic Bets Virtual Patching Can Calm AI Patch Chaos

Updated Category News Views 100

Three ugly outages in four days can make even hardened technology buyers reconsider the sacred ritual of “patch immediately.” Mimic’s new Virtual Patching offering arrives squarely in that uncomfortable gap: a vulnerability is known, attackers may be moving fast, and the proper vendor update still needs testing before somebody detonates production. The company’s...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 31

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 85

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
SQM Investigation Puts Chile Approval Claims on Trial

Updated Category News Views 71

A Regulatory Promise Meets a Rough Earnings Reaction A 5.52% haircut after disappointing quarterly numbers is the sort of thing that makes shareholders stop pretending every loose management comment is harmless. Sociedad Química y Minera de Chile, NYSE:SQM, is facing an investigation by Levi & Korsinsky into public statements concerning regulatory matters, particularly...

Continue Reading